Seed-stage milestones

Intellectual Property:


United States

Issued

  • U. S. Patent No. 10,602,939; issued March 2020

  • U.S. Patent No. 10,845,667; issued November 2020

Pending:

  • USPTO 16/685,260 Nov 2018

International Applications

  • PCT/US18/15953 January 2017

  • PCT/US19/34622 May 2018

  • PCT/US19/61874 November 2018

  • Taiwan Application No. 107103471 January 2017


Prototype manufacturing

Material Science: proof-of-concept testing

 

 Next-stage strategy

  • Scaled up prototyping and material science testing

  • Biological testing:

    • isolated neurons

    • cell cultures

    • ex vivo and  in vivo laboratory animals

    • intraoperative trial on human patients

  • MVP development and clinical trials

  • Add Machine Learning and Artificial Intelligence to create the next generation close-loop biofeedback systems

 

 Next-stage funding strategy

  • Governmental funding: DARPA, NIH, NSF, etc.

  • Private funding

  • Industry funding

  • Foundations: Alzheimer Association, Michael J. Fox Foundation, etc.

 

©2017-2021 BY NEUROSILICA, INC.